Donald G. Fell's most recent trade in Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A was a trade of 10,500 Common Stock, par value $0.0001 done at an average price of $0.4 . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aspire Biopharma Holdings Inc (Class A) | Donald G. Fell | Director | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 04 Jun 2025 | 10,500 | 20,000 | - | 0.4 | 4,095 | Common Stock, par value $0.0001 |
| Aspire Biopharma Holdings Inc (Class A) | Donald G. Fell | Director | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 04 Jun 2025 | 10,500 | 20,000 | - | 0.4 | 4,095 | Common Stock, par value $0.0001 |
| Aspire Biopharma Holdings Inc (Class A) | Donald G. Fell | Director | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 04 Jun 2025 | 9,500 | 9,500 | - | 0.4 | 3,705 | Common Stock, par value $0.0001 |
| Aspire Biopharma Holdings Inc (Class A) | Donald G. Fell | Director | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 04 Jun 2025 | 9,500 | 9,500 | - | 0.4 | 3,705 | Common Stock, par value $0.0001 |
| Scienture Holdings Inc | Donald G. Fell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 54,525 | 75,664 | - | 0 | Common stock | |
| Scienture Holdings Inc | Donald G. Fell | Director | Purchase of securities on an exchange or from another person at price $ 1.08 per share. | 25 Aug 2022 | 1,500 | 21,139 | - | 1.1 | 1,620 | Common Stock |
| Scienture Holdings Inc | Donald G. Fell | Director | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 12 May 2022 | 2,000 | 19,639 | - | 1.3 | 2,520 | Common Stock |